DEBORA SZAFRAN: Open Payments
NPI 1497815146 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$79 in 4 payments from 4 companies in 2025. Trend: 2023 $97 · 2024 $264 · 2025 $79
Food & beverage: $79
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $28 |
| UCB, Inc. | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $21 |
| Organon LLC | 1 | $4 |
Products named: OPZELURA, Bimzelx, TREMFYA, VTAMA.
Industry payments across PA — which companies pay providers there.
